Vivosim Lab Inc (VIVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,836 | 17,656 | 24,787 | 27,356 | 30,467 |
| Receivables | N/A | 19 | 84 | 111 | 165 |
| TOTAL | $20,099 | $19,485 | $25,501 | $28,318 | $31,106 |
| Non-Current Assets | |||||
| PPE Net | 289 | 22 | N/A | N/A | N/A |
| Other Non-Current Assets | 1,193 | 1,137 | 120 | 123 | 206 |
| TOTAL | $1,482 | $1,159 | $120 | $123 | $206 |
| Total Assets | $21,581 | $20,644 | $25,621 | $28,441 | $31,312 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 411 | 201 | 110 | 720 | 822 |
| Accrued Expenses | 418 | 457 | 725 | 1,090 | 1,536 |
| TOTAL | $829 | $658 | $835 | $1,810 | $2,358 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $829 | $658 | $835 | $1,810 | $2,358 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 593 | 561 | 544 | 544 | 544 |
| Common Shares | 7 | 7 | 131 | 7 | 130 |
| Retained earnings | -293,695 | -291,184 | -282,234 | -279,465 | -276,742 |
| Other shareholders' equity | -1 | -1 | 0 | 0 | 0 |
| TOTAL | $20,752 | $19,986 | $24,786 | $26,631 | $28,954 |
| Total Liabilities And Equity | $21,581 | $20,644 | $25,621 | $28,441 | $31,312 |